These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30820008)

  • 1. Quality of Life in Adolescent Boys with Idiopathic Short Stature: Positive Impact of Growth Hormone and Aromatase Inhibitors.
    Bullinger M; Bloemeke J; Mericq V; Sommer R; Gaete X; Ross JL; Yu YM; Permuy J; Gagliardi P; Damaso YL; Mauras N
    Horm Res Paediatr; 2018; 90(6):381-392. PubMed ID: 30820008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric performance of the Quality of Life in Short Stature Youth (QoLISSY) questionnaire in a randomized open-label comparator trial in idiopathic short stature.
    Bloemeke J; Balacano Valdez R; Mauras N; Mericq V; Ross J; Permuy J; Quitmann J; Bullinger M
    J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1089-1101. PubMed ID: 31557127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature.
    Mauras N; Ross JL; Gagliardi P; Yu YM; Hossain J; Permuy J; Damaso L; Merinbaum D; Singh RJ; Gaete X; Mericq V
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4984-4993. PubMed ID: 27710241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved General and Height-Specific Quality of Life in Children With Short Stature After 1 Year on Growth Hormone.
    González Briceño LG; Viaud M; Beltrand J; Flechtner I; Dassa Y; Samara-Boustani D; Thalassinos C; Pauwels C; Busiah K; Pinto G; Jaquet D; Polak M
    J Clin Endocrinol Metab; 2019 Jun; 104(6):2103-2111. PubMed ID: 30649493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological adaptation in children with idiopathic short stature treated with growth hormone or placebo.
    Ross JL; Sandberg DE; Rose SR; Leschek EW; Baron J; Chipman JJ; Cassorla FG; Quigley CA; Crowe BJ; Roberts K; Cutler GB
    J Clin Endocrinol Metab; 2004 Oct; 89(10):4873-8. PubMed ID: 15472178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Children's psychosocial functioning and parents' quality of life in paediatric short stature: The mediating role of caregiving stress.
    Silva N; Bullinger M; Sommer R; Rohenkohl A; Witt S; Quitmann J
    Clin Psychol Psychother; 2018 Jan; 25(1):e107-e118. PubMed ID: 28960605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvements in behaviour and self-esteem following growth hormone treatment in short prepubertal children.
    Chaplin JE; Kriström B; Jonsson B; Hägglöf B; Tuvemo T; Aronson AS; Dahlgren J; Albertsson-Wikland K
    Horm Res Paediatr; 2011; 75(4):291-303. PubMed ID: 21304250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric properties of the quality of life in short statured youth (QoLISSY) questionnaire within the course of growth hormone treatment.
    Bloemeke J; Silva N; Bullinger M; Witt S; Dörr HG; Quitmann J
    Health Qual Life Outcomes; 2019 Mar; 17(1):49. PubMed ID: 30885197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-year predictors of health-related quality of life changes in short-statured children treated with human growth hormone.
    Quitmann J; Bloemeke J; Dörr HG; Bullinger M; Witt S; Silva N
    J Endocrinol Invest; 2019 Sep; 42(9):1067-1076. PubMed ID: 30840207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP; Harris M; Choong CS; Ambler G; Cutfield W; Hofman P; Cowell CT; Werther G; Cotterill A; Davies PS;
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007.
    Heinks K; Boekhoff S; Hoffmann A; Warmuth-Metz M; Eveslage M; Peng J; Calaminus G; Müller HL
    Endocrine; 2018 Feb; 59(2):364-372. PubMed ID: 29230635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motives for choosing growth-enhancing hormone treatment in adolescents with idiopathic short stature: a questionnaire and structured interview study.
    Visser-van Balen H; Geenen R; Kamp GA; Huisman J; Wit JM; Sinnema G
    BMC Pediatr; 2005 Jun; 5(1):15. PubMed ID: 15943869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
    Kriström B; Aronson AS; Dahlgren J; Gustafsson J; Halldin M; Ivarsson SA; Nilsson NO; Svensson J; Tuvemo T; Albertsson-Wikland K
    J Clin Endocrinol Metab; 2009 Feb; 94(2):483-90. PubMed ID: 19001519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of spontaneous growth hormone secretory bursts and half-life of endogenous growth hormone in boys with idiopathic short stature. Genentech Collaborative Group.
    Veldhuis JDP6 ; Blizzard RM; Rogol AD; Martha PM; Kirkland JL; Sherman BM
    J Clin Endocrinol Metab; 1992 Apr; 74(4):766-73. PubMed ID: 1548338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone treatment and health-related quality of life in children and adolescents: A national, prospective, one-year controlled study.
    Butler G; Turlejski T; Wales G; Bailey L; Wright N
    Clin Endocrinol (Oxf); 2019 Aug; 91(2):304-313. PubMed ID: 31077606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of growth hormone treatment on craniofacial growth in children: Idiopathic short stature versus growth hormone deficiency.
    Choi SH; Fan D; Hwang MS; Lee HK; Hwang CJ
    J Formos Med Assoc; 2017 Apr; 116(4):313-321. PubMed ID: 27421175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in adolescents born small for gestational age: does growth hormone make a difference?
    Bannink EM; van Pareren YK; Theunissen NC; Raat H; Mulder PG; Hokken-Koelega AC
    Horm Res; 2005; 64(4):166-74. PubMed ID: 16205095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.